Le Lézard
Classified in: Health
Subject: PER

Advanced Laparoscopic Surgeons of Morris announced partnership with New York Bariatric Group


ROSLYN HEIGHTS, N.Y., May 7, 2024 /PRNewswire/ -- Advanced Laparoscopic Surgeons of Morris announces partnership with New York Bariatric Group (NYBG), the nation's leading private bariatric service provider offering bariatric surgical procedures and physician supervised weight loss with GLP-1 medications.

Advanced Laparoscopic Surgeons of Morris announced partnership with New York Bariatric Group

NYBG is the elite institution for the treatment of obesity. Developed through innovation and surgical excellency, NYBG aims to enhance access to innovative surgical techniques and exceptional patient care to new offices in Florham Park and Edison, New Jersey. This expands the NYBG footprint to 30 locations throughout the tri-state area.

Advanced Laparoscopic Surgeons of Morris founder, Dr. Alexander Abkin will be joining the distinguished NYBG team of 25 bariatric surgeons. With over two decades of dedicated service, Dr. Abkin has successfully performed more than 11,000 minimally invasive weight loss procedures, including gastric sleeve, gastric bypass, gastric banding, and revision surgery. His unwavering commitment to patient care, advanced surgical techniques, and remarkable surgical outcomes has earned him continued honorary distinctions and prestigious designations for the practice.

"We welcome Advanced Laparoscopic Surgeons of Morris and Dr. Abkin" says Dr. Shawn Garber, founder, and CEO of New York Bariatric Group. "This marks a significant milestone for expanding bariatric surgical experience and surgical excellence."

NYBG's comprehensive patient-centered approach to weight-loss includes an expedited one-day presurgical workup, aftercare program, support groups, nutrition services and products. The NYBG managed ambulatory surgery centers (ASC) further improves the patient experience by providing a fully operational modern facility for safe same-day surgical care.

"The mission to relentlessly focus on patient well-being and the delivery of top-quality care is further strengthened by the partnership with New York Bariatric Group" says Dr. Abkin. "With access to NYBG ASCs, we can offer our patients a superior alternative to traditional hospital stays for a safe and comfortable surgical experience."

About New York Bariatric Group

New York Bariatric Group (NYBG) is a nationally renowned bariatric practice. NYBG consults with patients on medical weight loss using GLP-1 agonists and performs a variety of weight loss procedures including gastric balloons, endoscopic sleeve gastroplasty, LAP-BAND© adjustable gastric band, revisional bariatric surgery, sleeve gastrectomy, duodenal switch, and gastric bypass. Utilizing minimally invasive techniques, technology, talent, and experience, New York Bariatric Group is the elite institution for the treatment of obesity. NYBG has 28 offices and 3 ambulatory surgery centers throughout New York, New Jersey, and Connecticut. Many patients can have same-day surgery in one of our bariatric specialty surgery centers. The only ambulatory surgery centers offering same day bariatric surgery in the tristate area.

NYBG accepts all major insurances. For more information or to schedule an appointment, call 800-633-8446 or visit stopobesityforlife.com.

Press Contact:

Megan DiGregorio


Director of Marketing Analytics and Business Development


Email: [email protected] 

Related Links  https://stopobesityforlife.com

Contact: New York Bariatric Group
www.StopObesityForLife.com
800-633-8446

SOURCE New York Bariatric Group


These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: